GetTopicDetailResponse(id=6b4d1652654, topicName=Sofosbuvir-Velpatasvir, introduction=Sofosbuvir-Velpatasvir, content=null, image=null, comments=2, allHits=1097, url=https://h5.medsci.cn/topic?id=16526, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=89234, tagList=[TagDto(tagId=89234, tagName=Sofosbuvir-Velpatasvir)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1972310, encodeId=903219e23105a, content=<a href='/topic/show?id=6b4d1652654' target=_blank style='color:#2F92EE;'>#Sofosbuvir-Velpatasvir#</a>, objectTitle=J Gastroenterology：含有或不含利巴韋林的sofosbuvir-velpatasvir在HCV感染失代償期肝硬化患者中的療效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=91, createdTime=2019-03-31, rootId=0, userName=tsing_hit, userId=dcaa509, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韋林的sofosbuvir-velpatasvir在HCV感染失代償期肝硬化患者中的療效和安全性分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972309, encodeId=8eec19e2309fa, content=<a href='/topic/show?id=6b4d1652654' target=_blank style='color:#2F92EE;'>#Sofosbuvir-Velpatasvir#</a>, objectTitle=Hepatology：DAA治療失敗的基因1 型丙型肝炎患者中，Sofosbuvir-velpatasvir-voxilaprevir使用效果評(píng)估, objectType=article, longId=100420, objectId=5e0f100420cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e0f100420cd, replyNumber=0, likeNumber=115, createdTime=2018-01-30, rootId=0, userName=tsing_hit, userId=dcaa509, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e0f100420cd, moduleTitle=Hepatology：DAA治療失敗的基因1 型丙型肝炎患者中，Sofosbuvir-velpatasvir-voxilaprevir使用效果評(píng)估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5e0f100420cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
